InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,821.34
(
0.10%
)
US TECH 100
19,596.80
(
-0.19%
)
Dow Jones
42,933.73
(
0.45%
)
Brent Oil
73.65
(
-1.11%
)
Bitcoin
67,657.82
(
0.97%
)
Post# of 429591
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

dmlcento

Send PM Follow Ignore
Followers 8
Posts 1820
Boards Moderated 0
Alias Born 01/24/2003

dmlcento

Re: ralphey post# 119934

Thursday, 12/28/2017 1:19:40 PM

Thursday, December 28, 2017 1:19:40 PM

Post# of 429591
So ralphey why did you prescribe Vascepa to some of your patients if you knew that this 2013 study said there was no CV benefit?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM

SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM

Future Hospitality Ventures Unveils Bold, New AI-Driven Initiative to Revolutionize the $300 Billion Hospitality Market • NGTF • Oct 16, 2024 7:07 AM

Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM

One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM

ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • BURU • Oct 15, 2024 8:21 AM

Start posting your company's news
Only $200 per official company press release!